Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with prosthetic valve thrombosis~Exclusion Criteria:~* Large left atrial thrombus~* Recent (\<3 weeks) ischemic stroke~* Hemorrhagic stroke~* Early (\<4 days) postoperative period~* Traumatic accident \<4 weeks~* Bleeding diathesis †~* İntracranial mass~* Active internal bleed~* Aortic dissection

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- rapid streptokinase (Type: ACTIVE_COMPARATOR): 3-hour infusion of 1.5 million units of streptokinase (16 patients, 16 episodes), repeat once 24 hours later if needed (maximum total dose 3 million units).
- high dose tpa (Type: ACTIVE_COMPARATOR): 5-hour infusion of 90 mg t-PA(Tissue plasminogen activator) after 10 mg bolus (10 patients, 12 episodes), repeat once 24 hours later if needed (maximum total dose 200 mg)
- slow streptokinase (Type: ACTIVE_COMPARATOR): 24-hour infusion of 1.5 million units of streptokinase (41 patients, 41 episodes), repeat once 24 hours later if needed (maximum total dose 3 million units).
- half-dose slow infusion tpa (Type: ACTIVE_COMPARATOR): 6-hour infusion of 50 mg t-PA (Tissue plasminogen activator) without bolus (27 patients, 27 episodes), repeat once 24 hours later up to 3 times if needed (maximum total dose 150 mg).
- low dose slow infusion tpa (Type: ACTIVE_COMPARATOR): 6-hour infusion of 25 mg t-PA(Tissue plasminogen activator) without bolus (108 patients, 124 episodes), repeat once 24 hours later up to 6 times if needed (maximum total dose 150 mg).

Based on this trial design, predict the completion outcome and termination type (if applicable).